Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.

Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J; Gaboxadol Study 99775 Group.

Sleep Med. 2009 Aug;10(7):705-12. doi: 10.1016/j.sleep.2008.09.010. Epub 2009 Apr 5.

PMID:
19346160
2.

4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships.

Frølund B, Jensen LS, Storustovu SI, Stensbøl TB, Ebert B, Kehler J, Krogsgaard-Larsen P, Liljefors T.

J Med Chem. 2007 Apr 19;50(8):1988-92. Epub 2007 Mar 22.

PMID:
17375905
3.

Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology.

Krehan D, Storustovu SI, Liljefors T, Ebert B, Nielsen B, Krogsgaard-Larsen P, Frølund B.

J Med Chem. 2006 Feb 23;49(4):1388-96.

PMID:
16480274

Supplemental Content

Loading ...
Support Center